Siegfried and DiNAQOR entered into an agreement relating to the acquisition by Siegfried of a 95% stake in DiNAQOR DiNAMIQS, a Swiss-based biotechnology company focused on the development and manufacturing of viral vectors for cell and
Tags :Slider
Emergent BioSolutions, the New York Stock Exchange listed developer and manufacturer of vaccines, completed the sale of its travel vaccine business to Bavarian Nordic for an upfront payment of USD 270 million. At closing Emergent received
NewBiologix, a technology company developing a proprietary platform focused on engineering cell lines used to manufacture gene and cell therapies, raised USD 50 million in series A financing. The round was led by Recipharm (an EQT
Homburger acted as counsel to Fluence in connection with certain financing aspects of the acquisition of Nispera. Headquartered in Arlington, USA, Fluence is a global provider of energy storage products, services and digital applications for
The CABB Group has successfully concluded its refinancing round. New bonds with a total volume of EUR 670 million and terms until 2028 were successfully placed with institutional investors. The issue comprises two tranches: EUR 420 million with
Credaris has purchased the credit intermediary CC Crédits Conseils, along with its call center in Tunisia. The acquisition of the 100% of the shares in the Swiss credit intermediary based in Versoix, further consolidates the
GAM Holding has entered into an agreement with Liontrust Asset Management relating to the launch by Liontrust of a public exchange offer for all publicly held shares in GAM. As further set out in the
NCAB Group, the global full-service supplier of printed circuit boards listed on Nasdaq Stockholm, has acquired the German db electronic, based in Waldshut-Tiengen in southern Germany, the db electronic in Switzerland and the db electronic
The Voigt Group and PHOENIX Pharma Switzerland have decided to bring their subsidiaries Voigt and Voigt Industrie Service and Amedis-UE respectively into a 50/50 joint venture. After receiving clearance from the Swiss Competition Commission, this closing
Walder Wyss advised UBS Switzerland as sole mandated lead arranger, sole bookrunner, agent and lender, as well as a syndicate of banks as lenders on a CHF 1.4 billion multicurrency syndicated revolving credit facility for Maus